BACKGROUND: Endothelial progenitor cells (EPCs) possess robust therapeutic angiogenic potential, yet may be limited in the capacity to develop into fully mature vasculature. This problem might be exacerbated by the absence of a neovascular foundation, namely pericytes, with simple EPC injection. We hypothesized that coculturing EPCs with smooth muscle cells (SMCs), components of the surrounding vascular wall, in a cell sheet will mimic the native spatial orientation and interaction between EPCs and SMCs to create a supratherapeutic angiogenic construct in a model of ischemic cardiomyopathy. METHODS AND RESULTS: Primary EPCs and SMCs were isolated from Wistar rats. Confluent SMCs topped with confluent EPCs were spontaneously detached from the Upcell dish to create an SMC-EPC bi-level cell sheet. A rodent ischemic cardiomyopathy model was created by ligating the left anterior descending coronary artery. Rats were then immediately divided into 3 groups: cell-sheet transplantation (n=14), cell injection (n=12), and no treatment (n=13). Cocultured EPCs and SMCs stimulated an abundant release of multiple cytokines in vitro. Increased capillary density and improved blood perfusion in the borderzone elucidated the significant in vivo angiogenic potential of this technology. Most interestingly, however, cell fate-tracking experiments demonstrated that the cell-sheet EPCs and SMCs directly migrated into the myocardium and differentiated into elements of newly formed functional vasculature. The robust angiogenic effect of this cell sheet translated to enhanced ventricular function as demonstrated by echocardiography. CONCLUSIONS: Spatially arranged EPC-SMC bi-level cell-sheet technology facilitated the natural interaction between EPCs and SMCs, thereby creating structurally mature, functional microvasculature in a rodent ischemic cardiomyopathy model, leading to improved myocardial function.
BACKGROUND: Endothelial progenitor cells (EPCs) possess robust therapeutic angiogenic potential, yet may be limited in the capacity to develop into fully mature vasculature. This problem might be exacerbated by the absence of a neovascular foundation, namely pericytes, with simple EPC injection. We hypothesized that coculturing EPCs with smooth muscle cells (SMCs), components of the surrounding vascular wall, in a cell sheet will mimic the native spatial orientation and interaction between EPCs and SMCs to create a supratherapeutic angiogenic construct in a model of ischemic cardiomyopathy. METHODS AND RESULTS: Primary EPCs and SMCs were isolated from Wistar rats. Confluent SMCs topped with confluent EPCs were spontaneously detached from the Upcell dish to create an SMC-EPC bi-level cell sheet. A rodent ischemic cardiomyopathy model was created by ligating the left anterior descending coronary artery. Rats were then immediately divided into 3 groups: cell-sheet transplantation (n=14), cell injection (n=12), and no treatment (n=13). Cocultured EPCs and SMCs stimulated an abundant release of multiple cytokines in vitro. Increased capillary density and improved blood perfusion in the borderzone elucidated the significant in vivo angiogenic potential of this technology. Most interestingly, however, cell fate-tracking experiments demonstrated that the cell-sheet EPCs and SMCs directly migrated into the myocardium and differentiated into elements of newly formed functional vasculature. The robust angiogenic effect of this cell sheet translated to enhanced ventricular function as demonstrated by echocardiography. CONCLUSIONS: Spatially arranged EPC-SMC bi-level cell-sheet technology facilitated the natural interaction between EPCs and SMCs, thereby creating structurally mature, functional microvasculature in a rodent ischemic cardiomyopathy model, leading to improved myocardial function.
Authors: William Hiesinger; Jose Manuel Perez-Aguilar; Pavan Atluri; Nicole A Marotta; John R Frederick; J Raymond Fitzpatrick; Ryan C McCormick; Jeffrey R Muenzer; Elaine C Yang; Rebecca D Levit; Li-Jun Yuan; John W Macarthur; Jeffery G Saven; Y Joseph Woo Journal: Circulation Date: 2011-09-13 Impact factor: 29.690
Authors: Michael Simons; Kari Alitalo; Brian H Annex; Hellmut G Augustin; Craig Beam; Bradford C Berk; Tatiana Byzova; Peter Carmeliet; William Chilian; John P Cooke; George E Davis; Anne Eichmann; M Luisa Iruela-Arispe; Eli Keshet; Albert J Sinusas; Christiana Ruhrberg; Y Joseph Woo; Stefanie Dimmeler Journal: Circ Res Date: 2015-04-30 Impact factor: 17.367
Authors: John W MacArthur; Amanda N Steele; Andrew B Goldstone; Jeffrey E Cohen; William Hiesinger; Y Joseph Woo Journal: Curr Treat Options Cardiovasc Med Date: 2017-04
Authors: Daniel von Bornstädt; Hanjay Wang; Michael J Paulsen; Andrew B Goldstone; Anahita Eskandari; Akshara Thakore; Lyndsay Stapleton; Amanda N Steele; Vi N Truong; Kevin Jaatinen; Camille Hironaka; Y Joseph Woo Journal: Circulation Date: 2018-11-06 Impact factor: 29.690
Authors: Jeffrey E Cohen; Brendan P Purcell; John W MacArthur; Anbin Mu; Yasuhiro Shudo; Jay B Patel; Christopher M Brusalis; Alen Trubelja; Alexander S Fairman; Bryan B Edwards; Mollie S Davis; George Hung; William Hiesinger; Pavan Atluri; Kenneth B Margulies; Jason A Burdick; Y Joseph Woo Journal: Circ Heart Fail Date: 2014-06-05 Impact factor: 8.790
Authors: Yasuhiro Shudo; Andrew B Goldstone; Jeffrey E Cohen; Jay B Patel; Michael S Hopkins; Amanda N Steele; Bryan B Edwards; Masashi Kawamura; Shigeru Miyagawa; Yoshiki Sawa; Y Joseph Woo Journal: J Thorac Cardiovasc Surg Date: 2017-05-24 Impact factor: 5.209
Authors: Yasuhiro Shudo; Jeffrey E Cohen; John W MacArthur; Andrew B Goldstone; Satoru Otsuru; Alen Trubelja; Jay Patel; Bryan B Edwards; George Hung; Alexander S Fairman; Christopher Brusalis; William Hiesinger; Pavan Atluri; Arudo Hiraoka; Shigeru Miyagawa; Yoshiki Sawa; Y Joseph Woo Journal: Tissue Eng Part A Date: 2015-09-18 Impact factor: 3.845
Authors: Yasuhiro Shudo; Jeffrey E Cohen; Andrew B Goldstone; John W MacArthur; Jay Patel; Bryan B Edwards; Michael S Hopkins; Amanda N Steele; Lydia-Marie Joubert; Shigeru Miyagawa; Yoshiki Sawa; Y Joseph Woo Journal: Cytotherapy Date: 2016-04 Impact factor: 5.414